Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,945–2,952 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Novartis AG Asciminib (ASC) - (ASC2ESCALATE) Chronic myeloid leukemia in chronic NDA Filing Ongoing Oral Oncology
Novartis AG Pelacarsen - (Lp(a)FRONTIERS APHERESIS) Cardiovascular disease NDA Filing Ongoing Subcutaneous Cardiology
Novartis AG Kesimpta (ofatumumab) - (ARTIOS) Relapsing multiple sclerosis (RMS) NDA Filing Data Released Subcutaneous Neurology
Novartis AG KLU156 (GanLum) Malaria NDA Filing Data Released Intravenous Antimalarial
Novartis AG Piqray - (BYLieve) Metastatic breast cancer (mBC) NDA Filing Data Released Oral Oncology
Novartis AG Leqvio - (VICTORION-1P) CVRR (Primary prevention) Phase 3 Ongoing Subcutaneous injection Cardiology
Novartis AG Zigakibart (BION-1301) - (BEYOND) IgA nephropathy Phase 3 Ongoing Intravenous #N/A
Novartis AG MONJUVI (tafasitamab) - (frontMIND) Diffuse Large B-Cell Lymphoma (DLBCL) Phase 3 Ongoing Intravenous Oncology